MIRA INFORM REPORT

 

 

Report Date :

16.07.2012

 

IDENTIFICATION DETAILS

 

Name :

KREMOINT PHARMA PRIVATE LIMITED

 

 

Registered Office :

Plot No.B-8, Additional Ambernath, M.I.D.C., Opposite Main Road, Anand Nagar Police Check Post, Ambernath (East), Mumbai-421506, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

12.05.1992

 

 

Com. Reg. No.:

11-066737

 

 

Capital Investment / Paid-up Capital :

Rs. 0.600 million

 

 

CIN No.:

[Company Identification No.]

U24230MH1992PTC066737

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMK05289E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Products

 

 

No. of Employees :

90 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (36)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 100000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record. Financial details of the company is missing from government department. However, trade relations are reported to be fair. Business is active. Payments are reported to be unknown.

 

The company can be considered for business dealing with some cautions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Ms. Madhuri

Designation :

Manager

Contact No.:

91-251-2620273

Date :

12.07.2012

 

 

LOCATIONS

 

Registered Office / Factory  :

Plot No.B-8, Additional Ambernath, M.I.D.C., Opposite Main Road, Anand Nagar Police Check Post, Ambernath (East), Mumbai-421506, Maharashtra, India

Tel. No.:

91-251-2620273 / 355 / 655 / 2621363 / 64 / 67 / 2620655 / 2620355

Fax No.:

91-251-2621363 / 365 / 367 / 2620273 / 355 / 655

E-Mail :

info@kremointpharma.com

Website :

www.kremointpharma.com

Area :

12000 Sq. Ft.

Location :

Owned

 

 

Warehouse :

D-59 / D-60, Additional Ambernath, M.I.D.C, Ambernath (East), Mumbai-421506, Maharashtra, India

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Mr. Bhadresh Keshavji Thakkar

Designation :

Director

Address :

151/5 Shree Krishna Nagar, Garodia Nagar, Ghatkopar, Mumbai – 400 077, Maharashtra, India

Date of Birth/Age :

07.12.1964

Qualification :

B.Com

Date of Appointment :

12.05.1992

DIN No.:

00774787

 

 

Name :

Mr. Ashwin Keshavji Thakkar

Designation :

Director

Address :

E 405/406, Panchan Balrajeshwar Road, Kalpanagari, Near Vaishali, Nagar, Mulund (West), Mumbai – 400 080, Maharashtra, India  

Date of Birth/Age :

17.07.1960

Qualification :

B. Tech

Date of Appointment :

12.05.1992

Date of Cessation :

29.06.2012

DIN No.:

00774807

 

 

Name :

Mr. S. N. Kamath

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Ms. Madhuri

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2011

 

Names of Shareholders

No. of Shares

Ashwin K Thakkar

1410

Bhadresh Thakkar

1990

Jyoti Ashwain Thakkar

660

Hema Bhadresh Thakkar

1210

Monil Ashwin Thakkar

730

TOTAL

6000

 

AS ON 30.09.2011

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Products

 

 

Products :

·         Ointments and Cream and Gel Formulations

·         Burns and Antiseptic Formulations

·         Pharmaceutical Formulations

·         Analgesic Formulations

·         Antiseptic / Antibactrial Formulations

·         Antifunagal Formulations

·         Acne Pimples Formulations

·         Corticosteroid / Antibactrial Formulations

·         Corticosteroid/Antibactrial/Antifungal Formulation

 

 

Exports :

 

Countries :

UK

 

 

Terms :

 

Selling :

Credit

 

 

Purchasing :

Credit

 

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers  

 

 

No. of Employees :

90 (Approximately)

 

 

Bankers :

·         The Bharat Co Operative Bank (Mumbai) Limited

Ghatkopar (West) Branch, 103 to 106, Jyoti Chambers, 1st Floor, Junction of J V Road, and Hirachand Desai Road, Mumbai - 400 086, Maharashtra, India 

 

·         Kotak Mahindra Bank

·         HDFC Bank

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2010

Rs. In Millions

31.03.2009

Motor Car Loan – HDFC

0.487

0.702

Motor Car Loan – Kotak Mahindra

0.818

0.000

Bharat Co-Operative Bank Limited (C. C. A/C)

4.898

8.632

 

 

 

Total

6.203

9.334

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2010

Rs. In Millions

31.03.2009

From Directors and Shareholders

11.879

10.880

 

 

 

Total

11.879

10.880

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

N M Associates

Chartered Accountant

Address :

1, Tarlika, Ground Floor, Sir Bhalchandra Road, Matunga, Mumbai – 400 019, Maharashtra, India

Tel. No.:

91-22-24141274 / 24144110

Pan No.:

AAAFN1489L

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

24000

Equity Shares

Rs.100/- each

Rs. 2.400 Millions

1000

Preference Shares

Rs.100/- each

Rs. 0.100 Million

 

TOTAL

 

Rs. 2.500 Millions

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

6000

Equity Shares

Rs.100/- each

Rs. 0.600 Million

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.600

0.600

0.600

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

26.857

22.629

20.069

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

27.457

23.229

20.669

LOAN FUNDS

 

 

 

1] Secured Loans

6.203

9.334

4.185

2] Unsecured Loans

11.879

10.880

8.879

TOTAL BORROWING

18.082

20.214

13.064

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

45.539

43.443

33.733

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

24.704

24.599

24.260

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.100

0.225

0.225

DEFERREX TAX ASSETS

0.054

0.216

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

15.009

11.153

7.860

 

Sundry Debtors

10.152

14.893

9.388

 

Cash & Bank Balances

0.253

0.081

0.121

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

13.250

6.836

4.617

Total Current Assets

38.664

32.963

21.986

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

8.552

8.143

7.281

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

9.431

6.417

5.457

Total Current Liabilities

17.983

14.560

12.738

Net Current Assets

20.681

18.403

9.248

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

45.539

43.443

33.733

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.208

 

SALES

 

 

 

 

 

Income

NA

NA

NA

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE TAX

6.225

3.891

3.601

 

 

 

 

 

Less

TAX                                                                 

1.823

1.155

0.980

 

 

 

 

 

 

PROFIT AFTER TAX

4.402

2.736

2.621

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

0.150

0.150

0.150

 

 

Dividend Distribution Tax

0.025

0.025

0.025

 

 

Transfer to General Reserve

0.100

0.100

0.100

 

BALANCE CARRIED TO THE B/S

4.127

2.461

2.346

 

 

 

 

 

 

Earnings Per Share (Rs.)

733.67

--

--

 

 

Particulars

 

 

31.03.2012

31.03.2011

Sales Turnover (Approximately)

 

170.000

100.000

 

 

 

 

 

Expected Sales (2012-2013) : Rs. 250.000 Millions

 

The above information has been parted by Ms. Madhuri.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.208

Return on Total Assets

(PBT/Total Assets}

(%)

9.82

6.73

7.79

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.17

0.17

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.31

1.50

1.25

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.15

2.26

1.72

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1.       Year of Establishment

Yes

2.       Locality of the firm

Yes

3.       Constructions of the firm

Yes

4.       Premises details

Yes

5.       Type of Business

Yes

6.       Line of Business

Yes

7.       Promoter’s background

Yes

8.       No. of Employees

Yes

9.       Name of person contacted

Yes

10.   Designation of contact person

Yes

11.   Turnover of firm for last three years

Yes

12.   Profitability for last three years

Yes

13.   Reasons for variation <> 20%

------

14.   Estimation for coming financial year

Yes

15.   Capital in the business

Yes

16.   Details of sister concerns

No

17.   Major suppliers

No

18.   Major customers

No

19.   Payments terms

Yes

20.   Export / Import details

Yes

21.   Market information

------

22.   Litigations that the firm / promoter involved

------

23.   Banking Details

Yes

24.   Banking facility details

Yes

25.   Conduct of the banking account

------

26.   Buyer visit details

------

27.   Financials, if provided

Yes

28.   Incorporation details, if applicable

Yes

29.   Last accounts filed at ROC

Yes

30.   Major Shareholders, if available

Yes

 

 

NOTE

 

Registered office has been shifted from Shree Krishna Darshan, 151/5 Garodia Nagar, Ghatkopar (East), Mumbai 400 077, Maharashtra, India to the present address w.e.f. 02.07.2012.

 

 

FORM 8

 

Corporate identity number of the company

U24230MH1992PTC066737

Name of the company

KREMOINT PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Shree Krishna Darshan, 151/5 Garodia Nagar, Ghatkopar (East), Mumbai 400 077, Maharashtra, India

This form is for

Creation of charge

Type of charge

·         Any interest in immovable property

·         Book debts

·         Movable property (not being pledge)

·         Others

Particular of charge holder

The Bharat Co Operative Bank (Mumbai) Limited

Ghatkopar (West) Branch, 103 to 106, Jyoti Chambers, 1st Floor, Junction of J V Road, and Hirachand Desai Road, Mumbai - 400 086, Maharashtra, India 

Nature of instrument creating charge

1) Memorandum of Entry Recording the deposit and Continuation of Deposit of Title Deeds.

 

2) Agreement for Hypothecation of Tangible Moveable Property.

 

3) Agreement for Creating Charge on Book Debts

 

(All the above documents constitute a single charge)

Date of instrument Creating the charge

11.10.2011

Amount secured by the charge

Rs. 44.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

Interest @ 13.50% p.a or such other rate as agreed between the borrower company and the bank from time to time.

Penal Interest, as agreed between the borrower company and the bank from time to time.

 

Terms of repayment

Repayment, as agreed between the borrower company and the bank from time to time.

 

Margin

Margin Rate, as agreed between the borrower company and the bank from time to time.

 

Extent and operation of the charge

At the request of the borrower company, the bank has sanctioned Term Loan of Rs. 44.000 Millions against Hypothecation of Stocks, book debts and Mortgage of Leasehold Rights of Plot No. B-8, Adm. 1140 meters in the Additional Ambernath Industrial Area, Village Limits : Ambernath, Taluka and Registration Sub-District Ulhasnagar, Thane, MIDC, Ambernath (East), Thane and Piece and Parcel of Land known as Plot No D 59, D 60 situated at Additional Ambernath Industrial Area, Thane.

Short particulars of the property charged (Including location of the property)

Mortgage of Leasehold Rights of Plot No. B-8, Adm. 1140 meters in the Additional Ambernath Industrial Area, Village Limits : Ambernath, Taluka and Registration Sub-District Ulhasnagar, Thane

 

Mortgage of Piece and Parcel of Land known as Plot No D 59, D 60 situated at Additional Ambernath Industrial Area, Thane.

 

Hypothecation of Stocks and Book Debts

 

 

FIXED ASSETS

 

·         Furniture

·         Computer

·         Land and Building

·         Plant and Machinery

·         Office Equipments

·         Mobile Phones

·         Air Conditioner

·         Security Systems

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 55.65

UK Pound

1

Rs. 85.88

Euro

1

Rs. 67.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

SBA

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

36

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.